Global Adipose Tissue Derived Stem Cell Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Adipose Tissue Derived Stem Cell Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The stem cells from adipose tissue have a variety of uses, including research on stem cell differentiation, cell therapy, tissue engineering, and the creation of induced pluripotent stem cell lineages. These are rich in multipotent stem cells, adipocytes, osteocytes, chondrocytes, and other cell types can all be differentiated into adipocytes, osteocytes, and other cell types in vitro.
Adipose Tissue Derived Stem Cell report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Adipose Tissue Derived Stem Cell market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Regenerative Medicine and Plastic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Adipose Tissue Derived Stem Cell industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Adipose Tissue Derived Stem Cell key manufacturers include Lonza, ThermoFisher Scientific Inc, Celprogen, Inc, iXCells Biotechnologies, Merck KGaA, Lifeline Cell Technology, AlloCure, Inc, Antria, Inc and Celgene Corporation, etc. Lonza, ThermoFisher Scientific Inc, Celprogen, Inc are top 3 players and held % sales share in total in 2023.
Adipose Tissue Derived Stem Cell can be divided into Source of Human Fat and Source of Animal Fat, etc. Source of Human Fat is the mainstream product in the market, accounting for % sales share globally in 2023.
Adipose Tissue Derived Stem Cell is widely used in various fields, such as Regenerative Medicine, Plastic Surgery and Other,, etc. Regenerative Medicine provides greatest supports to the Adipose Tissue Derived Stem Cell industry development. In 2023, global % sales of Adipose Tissue Derived Stem Cell went into Regenerative Medicine filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Adipose Tissue Derived Stem Cell market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Lonza
ThermoFisher Scientific Inc
Celprogen, Inc
iXCells Biotechnologies
Merck KGaA
Lifeline Cell Technology
AlloCure, Inc
Antria, Inc
Celgene Corporation
Cellleris SA
Corestem, Inc
Cytori Therapeutics, Inc
Intrexon, Inc
Mesoblast Ltd
Pluristem Therapeutics, Inc
Tissue Genesis
Segment by Type
Source of Human Fat
Source of Animal Fat
Regenerative Medicine
Plastic Surgery
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Adipose Tissue Derived Stem Cell market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Adipose Tissue Derived Stem Cell, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Adipose Tissue Derived Stem Cell industry.
Chapter 3Historical (2018-2023) and forecast (2023-2033) volume and revenue analysis of Adipose Tissue Derived Stem Cell in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Adipose Tissue Derived Stem Cell introduction, etc. Adipose Tissue Derived Stem Cell Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRA Research’s Conclusions of Adipose Tissue Derived Stem Cell market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRA Research.
Adipose Tissue Derived Stem Cell report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Adipose Tissue Derived Stem Cell market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Regenerative Medicine and Plastic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Adipose Tissue Derived Stem Cell industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Adipose Tissue Derived Stem Cell key manufacturers include Lonza, ThermoFisher Scientific Inc, Celprogen, Inc, iXCells Biotechnologies, Merck KGaA, Lifeline Cell Technology, AlloCure, Inc, Antria, Inc and Celgene Corporation, etc. Lonza, ThermoFisher Scientific Inc, Celprogen, Inc are top 3 players and held % sales share in total in 2023.
Adipose Tissue Derived Stem Cell can be divided into Source of Human Fat and Source of Animal Fat, etc. Source of Human Fat is the mainstream product in the market, accounting for % sales share globally in 2023.
Adipose Tissue Derived Stem Cell is widely used in various fields, such as Regenerative Medicine, Plastic Surgery and Other,, etc. Regenerative Medicine provides greatest supports to the Adipose Tissue Derived Stem Cell industry development. In 2023, global % sales of Adipose Tissue Derived Stem Cell went into Regenerative Medicine filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Adipose Tissue Derived Stem Cell market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Lonza
ThermoFisher Scientific Inc
Celprogen, Inc
iXCells Biotechnologies
Merck KGaA
Lifeline Cell Technology
AlloCure, Inc
Antria, Inc
Celgene Corporation
Cellleris SA
Corestem, Inc
Cytori Therapeutics, Inc
Intrexon, Inc
Mesoblast Ltd
Pluristem Therapeutics, Inc
Tissue Genesis
Segment by Type
Source of Human Fat
Source of Animal Fat
Segment by Application
Regenerative Medicine
Plastic Surgery
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Adipose Tissue Derived Stem Cell market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Adipose Tissue Derived Stem Cell, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Adipose Tissue Derived Stem Cell industry.
Chapter 3Historical (2018-2023) and forecast (2023-2033) volume and revenue analysis of Adipose Tissue Derived Stem Cell in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Adipose Tissue Derived Stem Cell introduction, etc. Adipose Tissue Derived Stem Cell Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRA Research’s Conclusions of Adipose Tissue Derived Stem Cell market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRA Research.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices